There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
"Ansell; J,; et al,: Drugs; 64; 1 (2004); Eriksson; B,; et al,: J, Thromb, Haemost,; 3; 103 (2005); Kubitza; D,; et al,: Clin, Pharmacol, Ther,; 78; 412 (2005);"
Synonyms
Not available
Application Notes
"A novel labelled antithrombotic agent. A highly potent and selective, direct FXa inhibitor.;Labeled Rivaroxaban, intended for use as an internal standard for the quantification of Rivaroxaban by GC- or LC-mass spectrometry."
Purity by HPLC
Not less than 90%
Hazard Compound
Refer MSDS for accurate information.
Overview
"A novel labelled antithrombotic agent. A highly potent and selective, direct FXa inhibitor.;Labeled Rivaroxaban, intended for use as an internal standard for the quantification of Rivaroxaban by GC- or LC-mass spectrometry."
